Board of Management


  • Dr. Carlo INCERTI, Sr. Vice President, Head of Global Medical Affairs, Chief Medical Officer, representing Genzyme Corporation


  • Mr. Robin EVERS, Chair of EuropaBio Healthcare Biotechnology Council; Senior Vice President Regulatory Affairs; representing Novo Nordisk A/S
  • Dr. Ricardo GENT, Chair of EuropaBio National Associations Council; Executive Director of the German Association of Biotechnology Industries (DIB)
  • Mrs. Leticia GONCALVES, Chair of the Agri-Food Council; President Europe and Middle East; representing Monsanto
  • Mr. Thomas Reese SAYLOR, Chair of the EuropaBio SME Platform; Chief Executive Officer, Arecor Ltd.
  • Mr Stephan TANDA, Chair of EuropaBio Industrial Biotechnology Council; Board Member Royal DSM 


  • Mrs. Petra LAUX, Head of Global Public and Goverment Affairs; representing Novartis (ad interim until June 2016)

Members of the Board

  • Mr. Steve BATES, Chief Executive Officer; representing the BioIndustry Association (BIA)
  • Mrs. Karin BERNADOTTE, Public Policy Lead; representing MSD Europe
  • Mr. Thomas BOLS, Vice President Public Policy & European Government Affairs, representing Biogen
  • Mr. Emmanuel CHANTELOT, Head of International Government Relations and Public Affairs; representing Shire
  • Mrs. Carmen EIBE GUIJARRO, representing ASEBIO
  • Mr. Marcel DANIËLS, Vice President of Government Affairs and Policy for the Europe & Canada Region; representing Merck Serono
  • Mrs. Tina FANOE, Vice President Business Operation EMA; representing Novozymes
  • Mr. Bernard GRIMM, Vice President Europe North, Western Europe and Canada; representing AbbVie
  • Dr. Peter HEINRICH, representing BIO Deutschland e.V.
  • Mr. Matthew MORAN, Head of the Irish Biotech Association, representing IBIA
  • Mr. David MORGAN, Head of Global Vegetables & Specialty Crops; representing Syngenta
  • Mr. Jeremy MORGAN, Vice President for Diabetes, International; representing Lilly
  • Dr. Maria Luisa NOLLI, representing Assobiotec
  • Dr. Walter PFEFFERLE, Senior Vice President Business Line Bioproducts, representing Evonik industries AG
  • Dr. Carsten SIEDEN, Senior Vice President White Biotechnology Research; representing BASF
  • Dr. Andrea RAPPAGLIOSI, Vice President Market Access, Vaccine Advocacy & Medical Affairs; representing Sanofi Pasteur MSD
  • Prof. Dr. Arjen VAN TUNEN, CEO; representing Keygene
  • Mrs. Annemiek VERKAMMAN, Managing Director; representing HollandBIO
  • Mrs. Nathalie MOLL, Secretary General; representing EuropaBio - ex-officio


Last update: 29 February 2016